Ozempic serves as a groundbreaking medication designed to assist individuals with type 2 diabetes in managing blood sugar levels. Manufactured by Novo Nordisk, this injectable treatment features the active ingredient Semaglutide, which acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. Its mechanism of action primarily involves stimulating insulin secretion in…